转甲状腺素蛋白淀粉样变或驱动腕管综合征腱鞘成纤维细胞纤维化与增殖
该研究评估了20例腕管松解手术患者的滑膜组织,比较TTR淀粉样变阳性与阴性组的基因表达,并用野生型和Val30Met突变型重组TTR体外处理阴性组成纤维细胞。结果发现TTR阳性组织纤维化、炎症和氧化应激相关基因上调,体外TTR处理促进胶原沉积和成纤维细胞增殖,抑制衰老通路。提示TTR沉积在腕管综合征中可能具有致病作用。
要点
- TTR阳性腕管综合征腱鞘组织中纤维化、炎症和氧化应激相关基因显著上调。
- 野生型和Val30Met突变型TTR均促进成纤维细胞胶原沉积和增殖,抑制衰老相关基因。
- 腕管综合征伴TTR沉积可能不仅是局部神经病变,TTR或参与发病机制。
核心结论
- TTR淀粉样变可促进腕管综合征患者成纤维细胞的纤维化、炎症和氧化应激相关基因表达,抑制衰老通路,并增强胶原沉积和成纤维细胞增殖。
研究设计与样本
- 研究纳入20例接受腕管松解手术患者的滑膜组织,评估TTR淀粉样变,比较TTR阳性与阴性组的纤维化、炎症和氧化应激相关基因表达。
- 从TTR阴性患者分离成纤维细胞,体外分别用野生型或Val30Met突变型重组TTR处理,进行定量RT-PCR、天狼星红染色、MTT增殖实验、活性氧检测和衰老相关基因表达分析。
主要发现
- TTR阳性组织中纤维化相关基因COL1A1、COL3A1、TGFB1、ACTA2,炎症介质NFKB1,以及氧化应激相关基因KEAP1、NQO1、SOD1显著上调,而SOD2下调。
- 体外实验中,野生型和Val30Met突变型TTR均增加COL3A1、IL6、CXCL8表达,Val30Met突变型TTR进一步增强IL1B表达。
- 天狼星红染色证实胶原沉积增加,MTT实验显示两组细胞活力均增加,表明成纤维细胞增殖增强。
- 衰老相关基因CDKN2D和GADD45A下调,提示增殖活性增强;活性氧活性在组间无显著差异。
临床怎么用
- 腕管综合征伴TTR沉积可能反映系统性淀粉样变早期表现,提示临床需关注全身性评估。
- TTR可能参与腕管综合征发病机制,为未来靶向治疗提供潜在方向。
局限性
- 样本量较小(20例),体外实验使用重组TTR处理分离的成纤维细胞,结果需进一步体内验证。
- 活性氧活性在组间无显著差异,氧化应激机制尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transthyretin (TTR) amyloid deposition in the tenosynovium in carpal tunnel syndrome (CTS) is a potential early manifestation of systemic amyloidosis. However, its effects on tenosynovial fibroblasts in CTS remain unclear. We aimed to clarify how wild-type and Val30Met mutant TTR amyloids affect tenosynovial fibroblasts in CTS. METHODS: Synovial tissue from 20 patients undergoing carpal tunnel release surgery was evaluated for TTR amyloid. Expression of genes related to fibrosis, inflammation, and oxidative stress was compared between TTR-positive and TTR-negative groups. Fibroblasts isolated from TTR-negative patients were treated in vitro with wild-type or Val30Met mutant recombinant TTR. Analyses included quantitative RT-PCR (reverse transcription-polymerase chain reaction), Picrosirius Red staining, MTT assays evaluating cell proliferation, reactive oxygen species (ROS) activity measurements, and senescence-related gene expression. RESULTS: In TTR-positive tissue, fibrosis-related genes ( COL1A1, COL3A1, TGFB1, and ACTA2 ), the inflammatory mediator NFKB1 , and oxidative-stress-related genes ( KEAP1, NQO1, and SOD1 ) were significantly upregulated, whereas SOD2 was downregulated. With in vitro treatment in the TTR-negative group, both wild-type and Val30Met TTR increased COL3A1, IL6, and CXCL8 expression, whereas Val30Met TTR further enhanced IL1B expression. Picrosirius Red staining confirmed increased collagen deposition. MTT assays revealed increased cell viability, indicating enhanced fibroblast proliferation, in both groups. The senescence-related genes CDKN2D and GADD45A were downregulated, suggesting enhanced proliferative activity. ROS activity did not differ significantly between groups. CONCLUSIONS: TTR amyloid was found to promote expression of fibrosis, inflammation, and oxidative-stress-related genes; inhibit senescence pathways; and enhance collagen deposition and fibroblast proliferation in fibroblasts from patients with CTS. CLINICAL RELEVANCE: CTS with TTR deposition may reflect more than a localized neuropathy, as TTR potentially plays a pathogenic role in CTS development. This finding provides novel insights into the underlying mechanisms of CTS.
引用
- Yamanaka Y, Tsujimura Y, Naito T, et al. Transthyretin Amyloid May Drive Fibrosis and Proliferation of Tenosynovial Fibroblasts in Carpal Tunnel Syndrome. J Bone Joint Surg Am. 2026. PMID: 41678652. doi:10.2106/JBJS.25.00807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。